Literature DB >> 12387584

Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes.

M R Gätke1, J Viby-Mogensen, J R Bundgaard.   

Abstract

BACKGROUND: The clinically important variants of butyrylcholinesterase (BChE) are the A- (Asp70Gly) and K-variants (Ala539Thr), which are common among Caucasians. These variants are associated with abnormal drug metabolism during anaesthesia, which leads to a prolonged neuromuscular block following administration of the neuromuscular blocking agents, mivacurium and succinylcholine. In addition, the K-variant has been proposed to be associated with Alzheimer's disease together with apolipoprotein E epsilon4. To facilitate diagnostics, we set out to establish a rapid and simple method for simultaneous genotyping of the A- and K-variants.
METHODS: Using the LightCycler, a rapid-cycle duplex PCR is combined with generation of allele-specific fluorescent probe melting profiles. This allows simultaneous detection of both of the mutations in the BChE gene. The results were compared with direct sequencing and phenotyping results.
RESULTS: Samples from 80 subjects were genotyped. The genotypes determined using the LightCycler were identical to those obtained by direct sequencing of conventional polymerase chain reaction products and was more accurate than phenotyping based on biochemical assays.
CONCLUSIONS: A high-speed and easy to perform mutation detection assay has been established for the two most common mutations, Asp70Gly and Ala539Thr, in BChE, using the LightCycler technology and melting curves.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387584     DOI: 10.1080/00365510260296537

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  Genotyping Parkinson disease-associated mitochondrial polymorphisms.

Authors:  Yiguo Jiang; Tammy Ellis; Anne R Greenlee
Journal:  Clin Med Res       Date:  2004-05

2.  Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.

Authors:  Shani Shenhar-Tsarfaty; Tal Bruck; Estelle R Bennett; Tsafrir Bravman; Einor Ben Aassayag; Nir Waiskopf; Ori Rogowski; Natan Bornstein; Shlomo Berliner; Hermona Soreq
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

3.  The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.

Authors:  Erez Podoly; Deborah E Shalev; Shani Shenhar-Tsarfaty; Estelle R Bennett; Einor Ben Assayag; Harvey Wilgus; Oded Livnah; Hermona Soreq
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.